Coronary Stent Market Size Set at USD 12.51 Billion by 2032

The coronary stent market, valued at USD 8.99 billion in 2023, is expected to reach USD 12.51 billion by 2032, growing at a compound annual growth rate (CAGR) of 3.6% from 2024 to 2032.

Download a sample of this report @ https://www.towardshealthcare.com/personalized-scope/5152

Table of Contents

Toggle

Key Market Insights

Dominant Product Segment: Drug-eluting stents (DES) held a 60% market share in 2023.
Regional Market Leader: North America led the market with a 37% share in 2023.
Fastest-Growing Segment: Bioresorbable Scaffold Systems (BRS) are projected to grow at a 5.2% CAGR during the forecast period.

Market Drivers and Trends

Rising Coronary Artery Disease (CAD) Incidence: The global burden of CAD, a leading cause of death, is driving demand for coronary stents. CAD is characterized by the accumulation of plaque in coronary arteries, restricting blood flow and causing conditions like chest pain, heart attacks, and heart failure.
Minimally Invasive Treatments Preferred: Patients and healthcare providers increasingly prefer percutaneous coronary intervention (PCI), a less invasive method that involves placing a coronary stent via catheter, due to its shorter recovery time, reduced pain, and shorter hospital stays compared to traditional bypass surgery.
Technological Advancements:
- Drug-Eluting Stents (DES): Designed to prevent restenosis by releasing medication to inhibit cell proliferation.
- Biocompatible Coatings: Reduces inflammation and risk of thrombosis.
- Flexible Stent Designs: Improved adaptability to various vessel shapes and diameters.
Cost-Effectiveness Focus: Efforts are ongoing to balance patient care with cost management. Strategies include promoting generic stents, implementing value-based pricing, negotiating bulk purchase agreements, and optimizing patient selection and procedural efficiencies.

Geographic Market Analysis

North America: Leading the global coronary stent market due to the high prevalence of CAD, advanced healthcare infrastructure, and comprehensive insurance coverage for stenting procedures.
Europe: A mature market characterized by strict regulations and a focus on cost-effectiveness. European companies are heavily involved in developing innovative stent technologies.
Asia-Pacific: Expected to see significant growth due to an increasing prevalence of CAD, improving healthcare infrastructure, and rising awareness of minimally invasive treatment options.

Future Market Outlook

The coronary stent market is poised for continued growth driven by technological advancements, an increasing aging population, and rising rates of diabetes and other lifestyle-related diseases. Innovations in stent design and materials, coupled with a demand for minimally invasive procedures, are expected to further propel market expansion.

Coronary Stent Market Companies

Biotronik SE & Co. KG
Cook
Terumo Corporation
Abbott
BD
MicroPort Scientific Corporation
B. Braun Melsungen AG
Boston Scientific Corporation
Medtronic

Coronary Stent Market Segments

(**We also provide cross-sectional analysis in market segments)

By Type

Bare Metal Stents (BMS)
Drug-eluting Stents (DES)
Bioresorbable Scaffold System (BRS)
Drug-eluting Balloons (DEB)

By End Use

Hospitals & Ambulatory Surgical Centers
Specialty Clinics
Others

By Geography

North America
Europe
Asia Pacific
Middle East and Africa
South America

Read Also: https://www.healthcarewebwire.com/spatial-omics-market-toc/
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/coronary-stent-market-sizing

To own our research study instantly, Click here @https://www.towardshealthcare.com/price/5152

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

2 weeks ago

Elena Morales

Elena Morales is a healthcare industry expert working at Healthcare Web Wire Consulting Firm, a subsidiary of Towards Healthcare. With her excellent knowledge of the field, Elena helps clients optimize their operations and navigate healthcare regulations. She's dedicated to staying updated on industry trends to make a positive impact on patient care. Elena is known for her professionalism and commitment to excellence, making her a valuable asset to any team.